Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewORYZON to present new clinical data and corporate updates at international conferences in...
Emerging Biotech Company Showcase organizado por NewYorkBIO y la Bolsa de Nueva York Spring European Virtual MidCap Event 31º Congreso Europeo de Microbiología Clínica y Enfermedades Infecciosas
-
New#NewMember | "AseBio allows to know the latest market trends and connect with the Spanish ...
Meet our new memeber DSM Pentapharm. We talk with Kally Wong, con la Business Director, Pharma and Head of R&D of the company.
-
NewMore than 160 spanish biotech companies seek out solutions for a greener industry
Most of these companies will be at the most important annual event for the sector, BIOSPAIN 2021, which will be held in Pamplona-Iruña from 27th September to 1rst October
-
NewORYZON announces FDA approval of IND for PORTICO, a Phase IIb trial with vafidemstat in Bo...
Recruitment ongoing in Europe. Primary objectives: to assess the effect of vafidemstat to address agitation and aggression and to improve overall disease
-
EventNutrEvent 2022
-
EventAgeingFIT 2022
-
NewORYZON presents iadademstat ALICE 30-month data at EHA-2021, confirming positive and robu...
Robust signals of clinical efficacy, with ORR of 83%, of which 67% are CR/CRi and five patients with responses longer than 1 year
-
-
NewAlgorithms and Image Biomarkers. Radiomics as another piece of precision oncology
Radiomics is revolutionising medical image interpretation
-
NewBIOSPAIN represents a boost for investment in a decisive year for biotechnology
The pandemic has provided an opportunity for Spanish biotechnology and private investment has increased by 50% in 2020. BIOSPAIN 2021, the reference Spanish trade fair for investment agents and
-
-
NewOWL Metabolomics and Sagimet Biosciences closed an agreement to use OWL´s services in Sagi...
In a recent Phase 2a trial, TVB-2640 improved serum biomarkers of liver injury in patients with nonalcoholic steatohepatitis (NASH). OWL has worked since 2019 as the provider of metabolomics services
-
NewLIM Global, Digital transformation and rebranding by eMascaró
The objectives were clear: communicate the brand's values, encourage customer attraction, entice more candidates and retain current customers.
-
NewYsios Capital closes its third fund at €216 million ($260 million)
Ysios BioFund 3 (YBF 3) is the firm’s largest fund to date. To invest in up to 15 companies in Europe and the US, with eight investments already made alongside top US and European investors
-
-
NewPandemic consolidates the trend of job and talent growth in the biotech sector
Biotech companies are expanding their workforce amid the pandemic, accentuating in 2020 the growth trend of recent years, in which staff increased by 7.6% in 2019 and accounted for 12.8% of people
-
AllyArvor Global Management, S.L.
Arvor is a business consultancy firm that focuses on advising management and managing business organisations in the health sector (pharma, medical devices, OTC, functional foods and nutritional
-
-
NewORYZON to present new clinical data and corporate updates at international conferences in...
The conferences are: BioEquity Europe Digital, Foro Medcap BME 2021, Oxford Global’s Online Drug Discovery Week, Jefferies Virtual Healthcare Conference 2021, Precision in Drug Discovery & Preclinical
-
NewAsabys Partners certifies with Bureau Veritas its Social Responsibility Management System...
Asabys, who has been in business for almost 3 years, has considered sustainability as a fundamental pillar of its strategic objectives since inception
-
OfferClinical Study Manager